Both the proliferation assay in vitro and tumor growth assay in vivo showed that 7E inhibited cyclin D1-mediated tumor growth, which indicates that IL-20 has an important regulatory role in HCC progression through cyclin D1. Here, IL20 is linked to hepatocellular carcinoma.